Why so many doses, and why now?

Why so many doses, and why now?

Saved in:

Bibliographic Details
Main Authors:	S Bilgic, B Akovalı
Format:	Article
Language:	English
Published:	Bioscientifica 2025-06-01
Series:	European Thyroid Journal
Subjects:	children and adolescents differentiated thyroid carcinoma dosimetry radioactive iodine therapy
Online Access:	https://etj.bioscientifica.com/view/journals/etj/14/3/ETJ-25-0115.xml
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Clinical experience in using lenvatinib in patients with progressive, radioactive iodine-refractory differentiated thyroid cancer
by: P. A. Isaev, et al.
Published: (2016-06-01)

Is hemi-thyroidectomy adequate in low risk differentiated thyroid cancer?
by: Justin Benjamin, et al.
Published: (2019-01-01)

Development and validation of a nomogram to predict failure of initial radioactive iodine therapy in differentiated thyroid cancer: a retrospective cohort study
by: Yulong Tang, et al.
Published: (2025-08-01)

Clinical outcome and influencing factors of differentiated thyroid cancer patients with radioiodine-refractory lung metastasis
by: Congcong Wang, et al.
Published: (2025-08-01)

POSTRADIAL SIALOZOADENITIS IN PATIENTS WITH PAPILLARY CARCINOMA OF THE THYROID GLAND
by: V. A. Kovalenko, et al.
Published: (2015-02-01)

Systemic Immune-Inflammation Index and Systemic Inflammation Response Index Predict the Response to Radioiodine Therapy for Differentiated Thyroid Cancer
by: Wang Y, et al.
Published: (2024-11-01)

Follow-up and transition of care for low recurrence risk thyroid cancer patients in Canada
by: Ralf Paschke, et al.
Published: (2025-06-01)

New-generation mutitargeted tyrosine kinase inhibitors in the treatment of radioactive iodine-refractory differentiated thyroid cancer
by: A. M. Mudunov
Published: (2015-06-01)

The incidence of hypothyroidism following the radioactive iodine treatment of graves' disease and the predictive factors influencing its development
by: Maha Husseni
Published: (2016-01-01)

An evaluation of deviation from the international atomic energy agency-international commission on radiological protection proposed equation for calculation of radiation dose rate emanating from the patients with differentiated thyroid cancer undergoing radioiodine (I-131) therapy
by: Forough Dehkordi, et al.
Published: (2017-04-01)

Efficacy and safety of anlotinib combined with 125I seed implantation for iodine-refractory thyroid cancer
by: Zhijun Chen, et al.
Published: (2025-08-01)

Why Integrity? Why Now?
by: Edwin C. Constable
Published: (2024-09-01)

High risk factors, molecular features and clinical management for radioactive iodine-refractory differentiated thyroid carcinoma
by: Tengyun Ma, et al.
Published: (2025-08-01)

Effectiveness of radioiodine therapy on preventing recurrence in differentiated thyroid carcinoma: a systematic review
by: Bima Indra, et al.
Published: (2025-05-01)

Iodine deficiency in the diet as a multidisciplinary problem
by: V. G. Bespalov, et al.
Published: (2021-06-01)

Urine iodine concentration in hospitalised infants with thyroid dysfunction
by: Christy Hou, et al.
Published: (2025-08-01)

Why so Slow?
by: Jasna Podreka
Published: (2024-09-01)

Local Charge Density Enhancement Strategy in Nitrogen‐rich Covalent Organic Framework for Boosted Iodine Removal From Water
by: Yue Ma, et al.
Published: (2025-08-01)

DOSIMETRY, RADIOEPIDEMIOLOGICAL AND REHABILITATION PROBLEMS AT THE LATE STAGE OF THE CHERNOBYL ACCIDENT
by: I. A. Likhtarov
Published: (2017-01-01)

Modern challenges of iodine nutrition: vegan and vegetarian diets
by: Laura Croce, et al.
Published: (2025-05-01)

Unusual false positive radioiodine uptake on 131 I whole body scintigraphy in three unrelated organs with different pathologies in patients of differentiated thyroid carcinoma: A case series
by: Rohit Ranade, et al.
Published: (2016-04-01)

Simulation and Validation of Dose Distribution in BNCT Treatment Planning System
by: LYU Tianqi, MENG Siqin, WANG Hongliang, HE Linfeng, RUAN Shihao, WANG Tianyun, WU Meimei, CHEN Jun, SHI Bin, GUAN Fengping, LI Yuqing, LI Tianfu, HAO Lijie, LIU Yuntao
Published: (2025-01-01)

Avaliação da qualidade da imagem e da Dose Glandular Média em Mamografia Digital.
by: Nathan Willig Lima, et al.
Published: (2015-05-01)

Thyroid carcinoma with thymus-like differentiation (CASTLE) tumor: а сase report
by: A. A. Ilyin, et al.
Published: (2021-08-01)

Maintaining euthyroidism: fundamentals of thyroid hormone physiology, iodine metabolism and hypothyroidism
by: De Wet Wolmarans
Published: (2017-08-01)

Editorial: Thyroid hormones and diet
by: Joao Anselmo, et al.
Published: (2025-08-01)

Accumulated dose stability parameters in p-type and n-type silicon diodes
by: Kelly Pascoalino, et al.
Published: (2025-02-01)

Relation between the thyroid diseases prevalence and doses of radiation exposure in the individuals relocated from radioactively contaminated areas in South Urals
by: E. I. Rabinovich, et al.
Published: (2022-04-01)

MORPHOBIOCHEMICAL FUNCTIONS OF THE SHEEP ORGANISM AND THEIR ADJUSTMENT IN THE CONDITIONS OF IODINE DEFICIENCY
by: M. I. Selionova, et al.
Published: (2019-04-01)

Investigation of 131I kinetics in the rats organism after a single intake
by: I. P. Drozd, et al.
Published: (2012-09-01)

Ecological aspects of studying the thyroid function of the thyroid gland in women of reproductive age living in a region with iodine deficiency (Akhtynsky district, Republic of Dagestan, Russia)
by: A. N. Dzhalilova, et al.
Published: (2024-10-01)

Comparison of TSH and Free T4 Hormone Levels in Individuals with Glucose-6-Phosphate Dehydrogenase Deficiency and Healthy Individuals
by: S Roozbahan, et al.
Published: (2025-01-01)

The Chernobyl – Thirty Years After The Post – Accidental Radiological – Hygienic and Medical Consequences
by: G. G. Onishchenko
Published: (2016-07-01)

EVALUATING LONG-TERM EXTERNAL DOSES AT SHORT RANGE IN PATIENTS RECEIVING 131I TREATMENT FOR DIFFERENTIATED THYROID CARCINOMA
by: Bilal Kovan, et al.
Published: (2024-07-01)

Why are there so few pathogens? Ecology and evolution in pathogen emergence
by: John M. Drake
Published: (2025-08-01)

THE ROLE OF BRAF MUTATION STATUS IN SURGICAL TREATMENT OF WELL-DIFFERENTIATED THYROID CANCER
by: A. P. Polyakov, et al.
Published: (2017-04-01)

Very low thyroglobulin level and rare metastatic location in radio-iodine refractory DTC should raise suspicion for initial misdiagnosis
by: Seyed Rasoul Zakavi, et al.
Published: (2025-06-01)

Internal doses to the public in the Fukushima prefecture from the Fukushima Daiichi NPP accident
by: I. A. Zvonova
Published: (2020-10-01)

Challenges in personal and clinical dosimetry using Li2B4O7 and MgB4O7 as TLD and OSLD
by: Leo Sousa Santiago de Oliveira, et al.
Published: (2022-07-01)

Why does Japan have so few cases of COVID‐19?
by: Akiko Iwasaki, et al.
Published: (2020-04-01)